Forum: Breast Cancer News
02-23-2011, 07:22 AM
|
Replies: 2
Views: 9,651
ER, PR & Her2 status may predict treatment
This Korean clinical study found for ER+ breast cancer, Pr negative status may predict poorer outcomes with Tamoxifen treatment and Her2 positive status may be best treated with long-term Her2-target...
|